“Long-Term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration ”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S25, https://doi.org/10.25251/skin.3.supp.25.